SC 13G Filing

Company

Theriva Biologics, Inc.

Filed

March 11, 1998

Accession Number

0000895813-98-000066

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →